ID
37646
Beschrijving
Study ID: 104864/612 Clinical Study ID: 104864/612 Study Title: A Prospective, Open Label Phase II Study to Evaluate the Efficacy and Safety of Topotecan (HycamtinTM) in Combination with Carboplatin as First-line Chemotherapy in Patients with Ovarian Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Trade Name: HycamtinTM Study Indication: Ovarian Cancer
Trefwoorden
Versies (1)
- 13-08-19 13-08-19 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
13 augustus 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Topotecan (HycamtinTM) with Carboplatin as First-Line Chemotherapy in Patients with Ovarian Cancer; 104864/612
Prior to Second Cycle
- StudyEvent: ODM
Beschrijving
Computed tomography
Alias
- UMLS CUI-1
- C0040405
Beschrijving
X-Ray Computed Tomography, Performed
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0040405
- UMLS CUI [1,2]
- C0884358
Beschrijving
X-Ray Computed Tomography, Changed status
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0040405
- UMLS CUI [1,2]
- C0443172
Beschrijving
X-Ray Computed Tomography, Finding
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0040405
- UMLS CUI [1,2]
- C0243095
Beschrijving
X-Ray Computed Tomography, Date in time
Datatype
date
Alias
- UMLS CUI [1,1]
- C0040405
- UMLS CUI [1,2]
- C0011008
Beschrijving
Assessment of response
Alias
- UMLS CUI-1
- C0521982
- UMLS CUI-2
- C0220825
Beschrijving
Response to treatment, Evaluation, Performed
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0521982
- UMLS CUI [1,2]
- C0220825
- UMLS CUI [1,3]
- C0884358
Beschrijving
Response to treatment, Evaluation
Datatype
text
Alias
- UMLS CUI [1,1]
- C0521982
- UMLS CUI [1,2]
- C0220825
- UMLS CUI [1,3]
- C0884358
Beschrijving
Response to treatment, Evaluation Method
Datatype
text
Alias
- UMLS CUI [1,1]
- C0521982
- UMLS CUI [1,2]
- C2911685
Beschrijving
Response to treatment, Evaluation, Date in time
Datatype
date
Alias
- UMLS CUI [1,1]
- C0521982
- UMLS CUI [1,2]
- C0220825
- UMLS CUI [1,3]
- C0011008
Beschrijving
Response to treatment, Evaluation, Malignant Neoplasms
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0521982
- UMLS CUI [1,2]
- C0220825
- UMLS CUI [1,3]
- C0006826
Beschrijving
Serious adverse events
Alias
- UMLS CUI-1
- C1519255
Beschrijving
Status of the study
Alias
- UMLS CUI-1
- C0008976
- UMLS CUI-2
- C0449438
Similar models
Prior to Second Cycle
- StudyEvent: ODM
C0884358 (UMLS CUI [1,2])
C0443172 (UMLS CUI [1,2])
C0243095 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0220825 (UMLS CUI-2)
C0220825 (UMLS CUI [1,2])
C0884358 (UMLS CUI [1,3])
C0220825 (UMLS CUI [1,2])
C0884358 (UMLS CUI [1,3])
C2911685 (UMLS CUI [1,2])
C0220825 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0220825 (UMLS CUI [1,2])
C0006826 (UMLS CUI [1,3])
C0008976 (UMLS CUI [1,2])